Dr. Ryan Beal, Founder and CEO of Dyve Biosciences, joins us to discuss an innovative approach to cancer treatment using transdermal drug delivery to target tumor acidity and support the immune system’s ability to fight cancer. With a background in medicine, pharmaceutical innovation, and entrepreneurship, Ryan shares insights into the…
How do science and regulatory strategy shape the future of medical devices? Join us on the MedTech Podcast with Sandi Schaible, Founder of Bonded in Science, as we explore chemical characterization, ISO 10993, and the importance of scientific leadership in advancing medical device safety. #MedTech #SandiSchaible #MedicalDevices #ISO10993 #RegulatoryStrategy
What happens when wearable sensor data meets clinical research and artificial intelligence? In Episode 140, we talk with Gennaro Maida, a healthcare technology executive whose work focuses on transforming sensor data into clinical evidence. Gennaro is CEO/CMIO of Denovo Innovations Group, Director of Clinical Products at Tactical Rehabilitation, and a…
The Future of Joint Repair: How 3D Printing Could Transform Orthopedic Care | Dr. Ben Holmes What if 3D printing could help repair damaged cartilage and restore joint function—before a patient needs a knee replacement? In this episode, we sit down with Dr. Ben Holmes, CEO and Co-Founder of Nanochon,…
In this episode, we sit down with Allison Komiyama, Founder of Bluestocking Health, to discuss medical devices, regulatory strategy, clinical evidence, and the challenges of bringing innovative technologies to market. Allison brings extensive experience in the medical device industry, having worked on hundreds of FDA pre-submissions and premarket submissions across…
In this episode, we talk with Daniel Zequeto, founder of ODC Life Sciences, about clinical development, patient recruitment, and the opportunities for biotech and pharmaceutical companies in Brazil and Latin America. With over 20 years of experience at Abbott, Hospira, Shire, and Alexion, Daniel shares valuable insights into what sponsors…
In this episode, we speak with **Dr. Satabhisa Mukhopadhyay**, Co-Founder and Chief Scientific Officer of 4D Path, about the intersection of physics, AI, and cancer research. Dr. Mukhopadhyay shares her journey from theoretical physics to cancer systems biology and AI/ML, and discusses how 4D Path’s QPOR™ technology uses computational approaches…
In this episode, we speak with Deborah Morley, a leading expert in cardiovascular innovation and medical device development. With a PhD in Cardiovascular Physiology and extensive experience across academia, clinical research, regulatory strategy, and industry, Deborah has played a key role in advancing Class III implantable cardiovascular devices, including LVADs…
In this episode, we sit down with Leonara Vidal, Global Clinical Affairs Lead at Gentell, to explore her international journey in clinical research, healthcare innovation, and medical devices. From her early work as a nurse and professor in Brazil to collaborating with Johns Hopkins University and USAID, Leonara has built…
In this episode, we sit down with Gerardo Noriega, a C-level executive, serial entrepreneur, inventor, and scholar with decades of experience in the global medical device industry. Gerardo has founded five medical device companies and has advised more than 50 medical technology startups and established companies across Silicon Valley. Throughout…
In this episode, we sit down with Matt DeNardo, a product and engineering leader with extensive experience in medical device development. Matt shares how successful products are created by balancing user needs, clinical value, regulatory strategy, and technical execution. Drawing from his background in systems engineering, design thinking, human factors,…
Join us for a conversation with Daniel S. Chen, MD, PhD, one of the leading voices in cancer immunotherapy. As the former Global Head of Cancer Immunotherapy Development at Genentech/Roche and current CEO of Synthetic Design Lab, Daniel shares lessons from developing groundbreaking therapies and his perspective on the future…
In this episode, Shareef Mahdavi explains why patient experience — not just clinical expertise — is the real driver behind growth. From increasing reviews from under 50 to more than 700, to nearly doubling monthly leads, Shareef shares how transforming the patient journey changed everything at Laser Eye Center of…
What if AI could completely change the way we understand disease and clinical trials? In this episode, we interview Dr. Joseph Geraci — mathematical physicist, AI researcher, and founder of NetraMark — about the future of explainable AI in medicine. Dr. Geraci’s background spans quantum computing, oncology, neuroscience, and machine…
Meet Gary K. Zammit—scientist, entrepreneur, and thought leader in the life sciences space. Gary is the founder and CEO of Clinilabs, a clinical research organization focused on CNS disorders, and the author of Beyond the Science. He is also a clinical professor of psychiatry at the Icahn School of Medicine…
In this episode, we bring together two outstanding leaders in clinical development to discuss the future of neuroscience and rare disease research. Joseph Grieco, VP and Head of Clinical Development at Tris Pharma, shares his experience leading innovative programs in neurological disorders, including pain, ADHD, opioid use disorder, and pediatric…
Meet Robert Packard, a medical device quality and regulatory expert with over 20 years of industry experience and 10+ years in biotech manufacturing. He’s led Quality and Regulatory Affairs at multiple startups, co-founded a laparoscopic imaging company, and served as a lead auditor and instructor for a major Notified Body.…
Discover how to successfully navigate the complex world of medical device regulations with Kristen Mittal, RAC, PMP — Co-Founder and CEO of Mittal Consulting. In this episode, Kristen shares insights from over a decade of experience working with startups and Fortune 500 companies, specializing in Class I, II, and III…
In this episode, we are joined by A/Prof Tina Soulis, a global leader in clinical research and biotechnology with over 30 years of experience across pharmaceuticals, medical devices, biotech, and academic research. Tina is the Founder and Director of Alithia Life Sciences, a full-service clinical CRO dedicated to advancing clinical…
In this episode, we’re joined by Gregory Mark Hill, Managing Partner at GCH Partners, who has spent more than 20 years working with entrepreneurs and growth-focused companies from New York to Silicon Valley and across international markets. Gregory shares insights from his experience in the world of capital, scaling businesses,…
In this episode, we sit down with physician, inventor, and serial entrepreneur David E. Albert, MD — a pioneer in digital cardiology who has spent more than three decades developing life-saving medical technologies that have transformed patient care. Dr. Albert is the founder of multiple health-tech companies and the creator…
In this episode, we’re joined by Alfonso, CEO at Leon Research and Managing Board Member at AICROS, to dive into leadership, growth, and innovation in clinical research. With 14 years of experience in executive and managerial roles—including over a decade in clinical investigation—Alfonso brings a unique, multidisciplinary perspective shaped by…
In this episode of Global Trial Accelerators, we sit down with Justin Chickles, CEO and co-founder of Glycyx Therapeutics, a clinical-stage biotech company taking on a hidden threat to cancer immunotherapy success: opioids. With over two decades of leadership across therapeutics, diagnostics, and digital health — including roles at Johnson…
In this episode, we welcome Steven Collens, CEO of MATTER, one of the world’s leading healthcare incubators and innovation hubs. Under Steven’s leadership, MATTER has supported more than 1,000 healthcare startups, helping innovators move faster, collaborate more effectively, and significantly improve their chances of success. MATTER works at the intersection…